| pubmed-article:19405135 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19405135 | lifeskim:mentions | umls-concept:C0206194 | lld:lifeskim |
| pubmed-article:19405135 | lifeskim:mentions | umls-concept:C0684336 | lld:lifeskim |
| pubmed-article:19405135 | lifeskim:mentions | umls-concept:C0238598 | lld:lifeskim |
| pubmed-article:19405135 | lifeskim:mentions | umls-concept:C0023452 | lld:lifeskim |
| pubmed-article:19405135 | lifeskim:mentions | umls-concept:C0205329 | lld:lifeskim |
| pubmed-article:19405135 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19405135 | pubmed:dateCreated | 2009-6-15 | lld:pubmed |
| pubmed-article:19405135 | pubmed:abstractText | Despite the extensive literature on neuropsychological sequelae after treatment of childhood acute lymphoblastic leukemia (ALL), the very-long-term neurocognitive outcome of the survivors is poorly studied. We assessed neuropsychological functioning in a population-based cohort of young adult childhood ALL survivors. | lld:pubmed |
| pubmed-article:19405135 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19405135 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19405135 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19405135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19405135 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19405135 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19405135 | pubmed:issn | 1545-5017 | lld:pubmed |
| pubmed-article:19405135 | pubmed:author | pubmed-author:BloiguRistoR | lld:pubmed |
| pubmed-article:19405135 | pubmed:author | pubmed-author:LanningMarjat... | lld:pubmed |
| pubmed-article:19405135 | pubmed:author | pubmed-author:Harila-SaariA... | lld:pubmed |
| pubmed-article:19405135 | pubmed:author | pubmed-author:WinqvistSatuS | lld:pubmed |
| pubmed-article:19405135 | pubmed:author | pubmed-author:HarilaMarika... | lld:pubmed |
| pubmed-article:19405135 | pubmed:copyrightInfo | (c) 2009 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:19405135 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19405135 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:19405135 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19405135 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19405135 | pubmed:pagination | 156-61 | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:meshHeading | pubmed-meshheading:19405135... | lld:pubmed |
| pubmed-article:19405135 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19405135 | pubmed:articleTitle | Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. | lld:pubmed |
| pubmed-article:19405135 | pubmed:affiliation | Department of Medical Research, Oulu University Hospital, Oulu, Finland. marika.harila@mail.suomi.net | lld:pubmed |
| pubmed-article:19405135 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19405135 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
